NEWS

Man on podium talking with sticker saying "cluster collaborations"

The Future of Cancer Treatment

For six years we have hosted The Future of Cancer Treatment (Fremtidens kreftbehandling) with the same partners. What is this seminar series all about?
En forsker undersøker et celler fra en kreftsvulst. Illustrasjonsfoto: AstraZeneca

Nye kreftbehandlinger krever nye samarbeidsformer

Debattinnlegg: Innføring av nye legemidler for små pasientgrupper tar unødvendig lang tid. Noen blir ikke tatt i bruk i Norge i det hele tatt. Det er en utfordring, skriver artikkelforfatterne.
Ola Gudmundsen, CEO LINK Medical, in a suit and tie, headshot, label in blue with the text "cluster collaborations".LINK Medical

Linking with the community

We want to highlight the fruitful collaborations in the cluster. In a new article series, we present members who have a cluster story to tell. This week, we meet LINK Medical.
Smiling and looking into the camera is Lars-Petter Strand, Head of Medical & Country Manager Norway og Gry Lønne Eriksson, Medical Advisor Hematology and Oncology, Novartis.Novartis

Novartis enters IMPRESS

Novartis joins the IMPRESS oncology study with six of its cancer medicines to treat up to one hundred patients.